MA (EU) number
EU/1/06/332/001
(Invented) 
name
Omnitrope
EU/1/06/332/002
Omnitrope
EU/1/06/332/003
Omnitrope
EU/1/06/332/004
Omnitrope
EU/1/06/332/005
Omnitrope
EU/1/06/332/006
Omnitrope
EU/1/06/332/007
Omnitrope
EU/1/06/332/008
Omnitrope
EU/1/06/332/009
Omnitrope
EU/1/06/332/010
Omnitrope
EU/1/06/332/011
Omnitrope
EU/1/06/332/012
Omnitrope
EU/1/06/332/013
Omnitrope
EU/1/06/332/014
Omnitrope
EU/1/06/332/015
Omnitrope
EU/1/06/332/016
Omnitrope
EU/1/06/332/017
Omnitrope
EU/1/06/332/018
Omnitrope
Strength
Pharmaceutical Form Route of 
Immediate Packaging
5 mg/ml
5 mg/ml
1.3 mg/ml
5 mg/1.5ml
5 mg/1.5ml
5 mg/1.5ml
Powder and solvent for 
solution for injection
Powder and solvent for 
solution for injection
Powder and solvent for 
solution for injection
Solution for injection in 
cartridge
Solution for injection in 
cartridge
Solution for injection in 
cartridge
10 mg/1.5ml Solution for injection in 
cartridge
10 mg/1.5ml Solution for injection in 
cartridge
10 mg/1.5ml Solution for injection in 
cartridge
15 mg/1.5ml Solution for injection in 
cartridge
15 mg/1.5ml Solution for injection in 
cartridge
15 mg/1.5ml Solution for injection in 
cartridge
Solution for injection in 
cartridge
Solution for injection in 
cartridge
Solution for injection in 
cartridge
10 mg/1.5ml Solution for injection in 
cartridge
10 mg/1.5ml Solution for injection in 
cartridge
10 mg/1.5ml Solution for injection in 
cartridge
5 mg/1.5ml
5 mg/1.5ml
5 mg/1.5ml
powder: vial (glass); 
solvent: vial (glass)
powder: vial (glass); 
solvent: cartridge (glass)
powder: vial (glass); 
solvent: cartridge (glass)
cartridge (glass)
cartridge (glass)
cartridge (glass)
cartridge (glass)
cartridge (glass)
cartridge (glass)
cartridge (glass) for 
SurePal 15
cartridge (glass) for 
SurePal 15
cartridge (glass) for 
SurePal 15
cartridge (glass) for 
SurePal 5
cartridge (glass) for 
SurePal 5
cartridge (glass) for 
SurePal 5
cartridge (glass) for 
SurePal 10
cartridge (glass) for 
SurePal 10
cartridge (glass) for 
SurePal 10
Administration
Subcutaneous 
use
Subcutaneous 
use
Subcutaneous 
use
Subcutaneous 
use
Subcutaneous 
use
Subcutaneous 
use
Subcutaneous 
use
Subcutaneous 
use
Subcutaneous 
use
Subcutaneous 
use
Subcutaneous 
use
Subcutaneous 
use
Subcutaneous 
use
Subcutaneous 
use
Subcutaneous 
use
Subcutaneous 
use
Subcutaneous 
use
Subcutaneous 
use
1/1
Content
(concentration)
powder: 1.5 mg; 
solvent: 1.13 ml
powder: 5.8 mg; 
solvent: 1.14 ml
powder: 5.8 mg; 
solvent: 1.14 ml
1.5 ml
1.5 ml
1.5 ml
1.5 ml
1.5 ml
1.5 ml
1.5 ml
1.5 ml
1.5 ml
1.5 ml
1.5 ml
1.5 ml
1.5 ml
1.5 ml
1.5 ml
Pack size
1 vial + 1 vial
1 vial + 1 
cartridge
5 vials + 5 
cartridges
1 cartridge
5 cartridges
10 cartridges
1 cartridge
5 cartridges
10 cartridges
1 cartridge
5 cartridges
10 cartridges
1 cartridge
5 cartridges
10 cartridges
1 cartridge
5 cartridges
10 cartridges
